Tolerance and Safety of an Oral Nutritional Supplement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-24

Study Completion Date

2021-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an open label, non-randomized, interventional, single arm study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tolerance and Safety of an Oral Nutritional Supplement (Adolescent Cohort)

NCT05923593

Healthy Volunteers

COMPLETED NA

Medium Chain Triglycerides Plasma Profile and Their Metabolites After Oral Peptamen Intake

NCT02241681

Healthy

COMPLETED NA

Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors

NCT00644098

People Who Are Overweight or Obesity

COMPLETED PHASE2

Oral Supplementation With a Black Pepper Extract

NCT05199012

Waist Circumference Triglycerides Appetite +2 more

COMPLETED NA

Genetic Basis for Prediction of Non-responders to Dietary Plant Sterol Intervention

NCT02765516

Hypercholesterolemia Cardiovascular Disease

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary objective is to assess whether the MAG oil (monoacylglycerol oil) containing study formula is well tolerated and safe when used as an ONS in healthy adults and adolescents.

Secondary objectives:

1. Describe the incidence and characteristics of possible gastrointestinal intolerance symptoms
2. Describe changes in stool characteristics, specifically stool frequency and consistency
3. Describe changes in anthropometric parameters, particularly weight and body mass index (BMI)
4. Describe changes in blood parameters of lipid metabolism
5. Describe changes in hematological and serum biochemistry parameters
6. Describe daily ONS intake and assess dietary adherence to the study protocol

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral nutritional supplement

Oral nutritional supplement that contains MAG oil

Group Type EXPERIMENTAL

MAG oil oral nutritional supplement (ONS)

Intervention Type DIETARY_SUPPLEMENT

The study product is suitable for use as an oral nutritional supplement (ONS).The study product contains MAG oil, hydrolyzed whey protein, simple carbohydrates, vitamins and minerals.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MAG oil oral nutritional supplement (ONS)

The study product is suitable for use as an oral nutritional supplement (ONS).The study product contains MAG oil, hydrolyzed whey protein, simple carbohydrates, vitamins and minerals.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers
* BMI range from \>18 to \<28 kg/m2 for adults with a minimum body weight of 45 kg
* BMI range between the 25th and 90th percentile according to the Swiss growth charts for adolescents with a minimum body weight of 40 kg
* Cohort 1: Adults aged 18+ years (6 males, 6 females)
* Cohort 2: Adolescents aged 12-17 years (6 males, 6 females)
* Deemed able to comply with study protocol for 2 weeks
* Able to obtain written informed consent from participants and /or legal guardians

Exclusion Criteria

* Pre-existing chronic medical or psychiatric conditions, as diagnosed by the treating physician
* Subjects taking dietary supplements (energy supplements, protein supplements) will be excluded. Subjects can continue taking vitamin or herbal supplements during the study period.
* Abnormal bowel transit, history of a gastrointestinal disorder (e.g., inflammatory bowel disease (IBD), diverticular disease, colon cancer, irritable bowel syndrome (IBS), history of chronic constipation with passage of fewer than 3 spontaneous bowel movements per week on average, or chronic or recurrent diarrhea with loose or watery bowel movements more than 3 times daily.
* Recent episode of an acute gastrointestinal illness with significant gastrointestinal symptoms in the 7 days prior to enrolment.
* Colonoscopy or other bowel cleansing procedures within 4 weeks prior to enrolment.
* Prior use of prescription medication(s), in particular antibiotics, antacids, laxatives or other medications impacting gastrointestinal transit time, within 8 weeks prior to enrolment.
* Significant medical or surgical event in the past 3 months potentially interfering with study procedures and assessments.
* Known food allergy in particular cow's milk protein allergy (CMPA) or known hypersensitivity/intolerance to any other ingredients in the study product.
* Known alcohol or substance abuse; specifically, alcohol intake \> 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer.
* Pregnant or lactating women or having given birth in the past 6 months prior to enrolment.
* Family or hierarchical relationships with Clinical Innovation Lab staff.

Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes